Ritholtz Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$940K Buy
2,430
+266
+12% +$98.6K 0.01% 640
2026
Q1
$633K Sell
2,164
-790
-27% -$260K 0.01% 700
2025
Q4
$1.04M Sell
2,954
-180
-6% -$60.8K 0.02% 515
2025
Q3
$1.01M Buy
3,134
+110
+4% +$34.2K 0.02% 499
2025
Q2
$1.18M Sell
3,024
-59
-2% -$23.7K 0.03% 423
2025
Q1
$1.34M Buy
3,083
+2,004
+186% +$804K 0.04% 335
2024
Q4
$398K Sell
1,079
-2,198
-67% -$920K 0.01% 623
2024
Q3
$1.7M Sell
3,277
-1,192
-27% -$637K 0.05% 261
2024
Q2
$2.42M Sell
4,469
-34
-0.8% -$18K 0.08% 165
2024
Q1
$2.34M Buy
4,503
+64
+1% +$31.8K 0.08% 167
2023
Q4
$2.09M Sell
4,439
-824
-16% -$381K 0.08% 161
2023
Q3
$2.29M Buy
5,263
+1,833
+53% +$831K 0.1% 120
2023
Q2
$1.52M Buy
3,430
+404
+13% +$186K 0.07% 184
2023
Q1
$1.39M Sell
3,026
-1,593
-34% -$758K 0.07% 187
2022
Q4
$2.37M Sell
4,619
-1,343
-23% -$682K 0.13% 111
2022
Q3
$2.71M Buy
5,962
+1,787
+43% +$855K 0.14% 95
2022
Q2
$2.02M Buy
4,175
+835
+25% +$413K 0.13% 88
2022
Q1
$1.64M Buy
3,340
+2,218
+198% +$1.01M 0.11% 116
2021
Q4
$520K Buy
1,122
+346
+45% +$146K 0.03% 294
2021
Q3
$289K Buy
776
+22
+3% +$8.36K 0.02% 376
2021
Q2
$288K Buy
+754
New +$288K 0.02% 374

Other funds holding ELV

Ritholtz Wealth Management's ELV Position: Q2 2026 in Review

Ritholtz Wealth Management increased its Elevance Health (ELV) stake by 12% in Q2 2026, buying an estimated $98.6K and bringing the position to 2,430 shares worth $940K. The position accounts for 0.01% of the portfolio, ranked #640.

Ritholtz Wealth Management first reported a position in ELV in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.71M in Q3 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Ritholtz Wealth Management held 2,430 shares of Elevance Health worth $940K as of Q2 2026.
  • Ritholtz Wealth Management bought 266 Elevance Health shares in Q2 2026, an estimated $98.6K.
  • Elevance Health made up 0.01% of Ritholtz Wealth Management's portfolio in Q2 2026, its #640 holding.
  • Ritholtz Wealth Management first reported a position in Elevance Health in Q2 2021 and has held it in 21 quarters since.
  • Ritholtz Wealth Management's Elevance Health position peaked at $2.71M in Q3 2022.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.